For patients with previously untreated chronic lymphocytic leukemia (CLL), fixed-duration acalabrutinib-venetoclax with or without obinutuzumab significantly prolongs progression-free survival ...

Researchers have found Brukinsa to be a potentially safer alternative for patients with chronic lymphocytic leukemia.

In this video, Jennifer A. Woyach, MD, discusses two abstracts from ASH Annual Meeting and Exhibition that evaluated the use of immune therapies to treat chronic lymphocytic leukemia.

Panelists discuss exciting updates on Bruton tyrosine kinase (BTK) inhibitors from the 2024 American Society of Hematology ...

Myeloid leukemias are among the most aggressive blood cancers and have low survival rates. Today, leukemia patients undergo ...

The price you pay for Gazyva depends on factors such as your dosage, whether you have health insurance, and the pharmacy you use. Financial assistance may be available to help you with the cost of ...

Brrr! As temperatures drop, you might think all you need to worry about is bundling up, but did you know you could actually ...

If there is a strong suspicion of lymphocytic hypophysitis and there is no visual loss, then corticosteroid therapy is usually given as first-line management. It is important to measure IgG4 ...

Feb. 21, 2025 — Researchers used visual threat manipulation in the virtual reality environment and thermal stimulation to investigate how the brain perceives pain. They found that the brain ...

GAD is a common mental illness that is characterized by excessive, chronic worry that interferes with a ... accompanied by physical symptoms, and cause significant distress and impairment in their ...

A woman’s risk for blood clots varied by the type of hormonal contraception used, according to a nationwide cohort study conducted in Denmark.